These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Alpha-interferon therapy increases serum beta2-microglobulin levels in hemodialysis patients. Espinosa M; Martin-Malo A; Alvarez de Lara MA; Navarro MD; Aljama P Clin Nephrol; 2001 Nov; 56(5):378-81. PubMed ID: 11758008 [TBL] [Abstract][Full Text] [Related]
28. Neurofilament light as a prognostic marker in multiple sclerosis. Salzer J; Svenningsson A; Sundström P Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018 [TBL] [Abstract][Full Text] [Related]
29. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis. Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743 [TBL] [Abstract][Full Text] [Related]
30. Beta2 microglobulin as a surrogate marker for HIV infection: good correlation with CD4 counts. Wanchu A; Arora S; Bhatnagar A; Sud A; Bambery P; Singh S Indian J Pathol Microbiol; 2004 Apr; 47(2):298-301. PubMed ID: 16295507 [TBL] [Abstract][Full Text] [Related]
31. Prognostic values of serum cystatin C and beta2 microglobulin, urinary beta2 microglobulin and N-acetyl-beta-D-glucosaminidase in early acute renal failure after liver transplantation. Hei ZQ; Li XY; Shen N; Pang HY; Zhou SL; Guan JQ Chin Med J (Engl); 2008 Jul; 121(14):1251-6. PubMed ID: 18713542 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis. Sormani MP; Stubinski B; Cornelisse P; Rocak S; Li D; De Stefano N Mult Scler; 2011 May; 17(5):541-9. PubMed ID: 21148262 [TBL] [Abstract][Full Text] [Related]
33. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898 [TBL] [Abstract][Full Text] [Related]
34. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related]
35. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin]. Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382 [TBL] [Abstract][Full Text] [Related]
36. Fetal serum beta2-microglobulin as a marker for fetal infectious diseases. Dreux S; Rousseau T; Gerber S; Col JY; Dommergues M; Muller F Prenat Diagn; 2006 May; 26(5):471-4. PubMed ID: 16652403 [TBL] [Abstract][Full Text] [Related]
37. [Serum neopterin and beta2-microglobulin concentration as "prognostic markers" of AIDS]. Halota W; Jaruga B; Pawłowska M Pol Merkur Lekarski; 2002 Aug; 13(74):126-8. PubMed ID: 12420343 [TBL] [Abstract][Full Text] [Related]
38. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis. Bilińska M; Frydecka I; Podemski R; Gruszka E Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926 [TBL] [Abstract][Full Text] [Related]
39. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data. Enzinger C; Fuchs S; Pichler A; Wallner-Blazek M; Khalil M; Langkammer C; Ropele S; Fazekas F Mult Scler; 2011 Jun; 17(6):695-701. PubMed ID: 21228028 [TBL] [Abstract][Full Text] [Related]